España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Tharimmune
THAR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.98
0.00
0.00%
At close: -
$1.95
-0.03
-1.52%
After Hours: 6:50 PM EDT
Get Report
Comment
Tharimmune (THAR) Forecast
News
Earnings
Tharimmune (THAR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Tharimmune (NASDAQ:THAR) Stock
Tharimmune Stock (NASDAQ: THAR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 06, 2024
Tharimmune shares are trading higher after it...
Benzinga Newsdesk
Tharimmune Has Entered Into A Securities Purc...
Benzinga Newsdesk
Rodman & Renshaw Initiates Coverage On Tharim...
Benzinga Newsdesk
Monday, November 18, 2024
What's Going On With Tharimmune Shares Monday?
Dylan Berman
Tharimmune shares are trading higher after th...
Benzinga Newsdesk
Tharimmune Announces Presentation At AASLD Th...
Benzinga Newsdesk
Wednesday, November 13, 2024
Tharimmune shares are trading higher after th...
Benzinga Newsdesk
Tharimmune Granted European Patent Covering B...
Benzinga Newsdesk
Monday, November 04, 2024
10 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Wednesday, October 30, 2024
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
Avi Kapoor
S&P 500 Edges Lower; US Crude Oil Inventories Fall
Avi Kapoor
What's Going On With Tharimmune Shares Wednesday?
Dylan Berman
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Dow Surges Over 150 Points; Alphabet Posts Upbeat Results
Avi Kapoor
Tharimmune shares are trading higher after th...
Benzinga Newsdesk
Tharimmune Receives EMA Feedback On TH104 Cli...
Benzinga Newsdesk
Monday, October 28, 2024
Tharimmune Presents Phase 1 Data On TH104 For...
Benzinga Newsdesk
Friday, October 04, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, September 30, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Monday, September 16, 2024
Tharimmune Partners with Intract Pharma to De...
Benzinga Newsdesk
Thursday, June 20, 2024
Tharimmune shares are trading higher after th...
Benzinga Newsdesk
Tharimmune Announces Securities Purchase Agre...
Benzinga Newsdesk
Monday, June 17, 2024
Tharimmune Reports Type C Meeting With FDA Fo...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Tuesday, June 11, 2024
Tharimmune Receives Notice From Nasdaq Confir...
Benzinga Newsdesk
Monday, June 10, 2024
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Tharimmune shares are trading lower after the...
Benzinga Newsdesk
Why Tharimmune (THAR) Shares Are Getting Hammered
Henry Khederian
Reported Friday, "Tharimmune Enters ATM Agree...
Benzinga Newsdesk
Friday, May 24, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Wednesday, May 22, 2024
Tharimmune shares are trading lower after the...
Benzinga Newsdesk
Why Tharimmune (THAR) Shares Are Moving
Henry Khederian
Tharimmune Earlier Announced A 1-For-15 Rever...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, April 23, 2024
Tharimmune Announced An Option Agreement For ...
Benzinga Newsdesk
Monday, April 15, 2024
Tharimmune Forms Scientific Advisory Board To...
Benzinga Newsdesk
Tuesday, February 20, 2024
Tharimmune's Oral 'Under The Cheek' Candidate At Par With FDA-Approved Injectable With Potential For Chronic Liver Disease
Vandana Singh
Tharimmune Announces Results In Phase 1 Clini...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, February 05, 2024
Tharimmune Announces Dosing Of First Patient ...
Benzinga Newsdesk
Monday, January 29, 2024
Tharimmune Has Initiated A Phase 1 Trial With...
Benzinga Newsdesk
Thursday, January 25, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, January 24, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, December 19, 2023
Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying
Avi Kapoor
Monday, December 11, 2023
Tharimmune Announces Topline Data With TH104,...
Benzinga Newsdesk
Friday, December 08, 2023
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, December 07, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Monday, December 04, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Tuesday, November 28, 2023
Crude Oil Surges 2%; Tharimmune Shares Plummet
Lisa Levin
Show More